药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Eslicarbazepine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eslicarbazepine.
Potassium cation
Lithium carbonate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lithium carbonate.
Potassium cation
Aripiprazole lauroxil
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Aripiprazole lauroxil.
Potassium cation
Cannabidivarin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cannabidivarin.
Potassium cation
Nordazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nordazepam.
Potassium cation
5-methoxy-N,N-dimethyltryptamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with 5-methoxy-N,N-dimethyltryptamine.
Potassium cation
MRK-409
The risk or severity of adverse effects can be increased when Cannabidiol is combined with MRK-409.
Potassium cation
Cyclopropane
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cyclopropane.
Potassium cation
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine.
Potassium cation
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
Potassium cation
Brofaromine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brofaromine.
Potassium cation
Harmaline
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Harmaline.
Potassium cation
Lormetazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lormetazepam.
Potassium cation
Clopenthixol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clopenthixol.
Potassium cation
Doxefazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Doxefazepam.
Potassium cation
Carbromal
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Carbromal.
Potassium cation
Reposal
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Reposal.
Potassium cation
Ethadione
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ethadione.
Potassium cation
Penfluridol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Penfluridol.
Potassium cation
Tilidine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tilidine.